This video is a part of our ESG Special Report week
This video is a part of our ESG Special Report week
These stocks are each trading at over a 30% discount to our fair value estimates
With the medical marijuana market expected to hit US$ 40 billion by 2024, and the potential for c...
The reasons for price rises and what the hostile rhetoric means for pharma companies
CPMS's Phil Dabo finds superior risk-adjusted returns alongside strong cash flow characteristics
Ian Tam outlines how to identify funds involved in the fossil fuel business and champions of the ...
Eventually, ETFs will be the industry standard
The price of the radioactive metal rose last year - what's behind the recent optimism? We ask sec...
CPMS's Phil Dabo finds superior risk-adjusted returns alongside strong cash flow characteristics
Demand for COVID-19 vaccines has seen interest in pharma stocks soar, but Morningstar analysts th...
How can you get in the best financial shape at the start of the year?
Security Name | Price | Change (%) | Morningstar Rating |
---|---|---|---|
McKesson Corp | 185.01 USD | 1.21 | ![]() |
Teva Pharmaceutical Industries Ltd ADR | 12.55 USD | 4.85 | ![]() |